Henrik Zetterberg

Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

K. Blennow, J. Soucy, P. Rosa-Neto, 2024, Molecular neurodegeneration.

Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project

K. Blennow, J. Fitzsimmons, H. Protas, 2024, Journal of neuroinflammation.

Repetitive head injuries in German American football players do not change blood-based biomarker candidates for CTE during a single season

K. Blennow, N. Ashton, A. Albuş, 2024, Neurological research and practice.

Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19

K. Blennow, L. Havdal, Tonje Stiansen-Sonerud, 2024, Frontiers in neurology.

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

K. Blennow, A. Lleó, E. Vanmechelen, 2024, JAMA neurology.

Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings

K. Blennow, L. Montoliu-Gaya, A. Orellana, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

A Nonlinear Relation between Body Mass Index and Long-Term Poststroke Functional Outcome—The Importance of Insulin Resistance, Inflammation, and Insulin-like Growth Factor-Binding Protein-1

K. Blennow, N. Åberg, C. Jern, 2024, International journal of molecular sciences.

Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals

K. Blennow, S. Sandberg, A. Jeromin, 2023, medRxiv.

Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects

K. Blennow, Yi Li, Patrick Harvey, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.